Neuberger Berman Group LLC Voyager Therapeutics, Inc. Transaction History

Neuberger Berman Group LLC

  • $118 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 12, 2019
SELL
$8.59 - $18.05 $177,778 - $373,562
-20,696 Closed
0 $0
Q2 2018

Aug 13, 2018
BUY
$16.76 - $23.92 $7,642 - $10,907
456 Added 2.25%
20,696 $404,000
Q1 2018

May 08, 2018
BUY
$16.16 - $31.31 $151,096 - $292,748
9,350 Added 85.86%
20,240 $380,000
Q4 2017

Feb 14, 2018
BUY
$12.26 - $25.88 $133,511 - $281,833
10,890
10,890 $181,000

Others Institutions Holding VYGR

# of Institutions
134
Shares Held
34.2M
Call Options Held
35.3K
Put Options Held
63K
View Full List

About Voyager Therapeutics, Inc.

VYGR Quotes by TradingView
  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $293M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email